November 5, 2019 - H.I.G. BioHealth Provides Equity Financing for Clarify Medical

MIAMI – November 5, 2019 – H.I.G. BioHealth Partners (“H.I.G.”), the dedicated healthcare investment affiliate of H.I.G. Capital, a leading global private equity investment firm with over $34 billion of equity capital under management,* co-led an $18M commercialization round…

November 4, 2019 - H.I.G. Capital Completes Acquisition of BioVectra

MIAMI – November 4, 2019 – H.I.G. Capital ("H.I.G."), a leading global private equity investment firm with over $34 billion of equity capital under management, is pleased to announce that one of its affiliates has completed the acquisition of BioVectra Inc. (“BioVectra” or the…

July 30, 2019 - Exagen Inc. Expands Board of Directors with its Appointment of Chet Burrell, Tina Nova and Bruce Robertson

SAN DIEGO, CA & ALBUQUERQUE, NM – July 30, 2019 - Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis, prognosis, and monitoring while optimizing…

July 16, 2019 - Exagen Inc. Completes $22.6 Million Financing

SAN DIEGO, CA & ALBUQUERQUE, NM – July 16, 2019 - Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis, prognosis, and monitoring while optimizing…

June 24, 2019 - Apollo Endosurgery Announces Completion of Patient Enrollment for the Multi-Center ESG Randomized Interventional Trial (MERIT)

AUSTIN, TX - June 24, 2019 - Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the final patient has been enrolled in the Multi-Center ESG Randomized Interventional Trial…

June 18, 2019 - H.I.G. BioHealth Partners Completes Sale of Vertiflex to Boston Scientific

MIAMI – June 18, 2019 - H.I.G. BioHealth Partners (“H.I.G.”), the dedicated healthcare investment affiliate of H.I.G. Capital, a leading global private equity investment firm with over $30 billion of equity capital under management,* recently announced the sale of Vertiflex, Inc.…

June 18, 2019 - Journal of Endovascular Therapy Publishes Peer Reviewed Article Underscoring the Clinical Impact of Post-Angioplasty Dissections

WAYNE, PA – June 18, 2019 - Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today welcomed the peer-reviewed publication, “Dissections After Infrainguinal Percutaneous Transluminal Angioplasty (PTA): Systematic Review…

June 18, 2019 - CardioFocus Launches 100th HeartLight® Center Worldwide

MARLBOROUGH, MA – June 18, 2019 – CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), announced today that the HeartLight® Endoscopic Ablation System is now offered at more than 100 hospitals worldwide. The HeartLight…

June 17, 2019 - Neurana Pharmaceuticals Announces Completion of Enrollment in the Phase 2 Study of Tolperisone

SAN DIEGO – June 17, 2019 – Neurana Pharmaceuticals, a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today announced that it has completed enrollment in the "STAR Study," a Phase 2 dose ranging study of tolperisone in acute muscle spasms…

May 10, 2019 - CardioFocus Announces Impressive Results from Pivotal Confirmatory Study with the Breakthrough HeartLight® X3 System

MARLBOROUGH, MA – May 10, 2019 - CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3 System for the treatment…